Association of MRI Visible Perivascular Spaces and Neurofilament Light Chain: The Framingham Heart Study

BACKGROUND Neurofilament light chain (NfL) is a marker of neuronal injury. Perivascular spaces (PVS) visible on magnetic resonance imaging (MRI) represent cerebral small vessel disease (CSVD) but their role as markers of neuronal injury needs further clarification. OBJECTIVE To relate PVS burden according to brain topography and plasma NfL. METHODS Framingham Heart Study (FHS) participants with brain MRI and NfL measurements were included. PVS were rated in the basal ganglia (BG) and centrum semiovale (CSO) using validated methods and categorized based on counts. A mixed region variable representing high burden PVS in either BG or CSO was assessed. Multivariable linear regression analyses were used to relate PVS burden to log-transformed NfL levels in models adjusted for age, sex, FHS cohort, time between MRI and clinic exam, and image view (model 1), vascular risk factors (model 2), and white matter hyperintensity volume, covert brain infarcts, and cerebral microbleeds (model 3). RESULTS Among 1,457 participants (68.1±8.5 years, 45% males), NfL levels increased with higher PVS burden. Multivariable analysis showed an association of high PVS burden strictly in BG with NfL (β= 0.117, 95% CI 0.014-0.221; p = 0.027), but attenuated in model 3. The associations were mainly in participants≥65 years (β= 0.122, 95% CI 0.015-0.229, p = 0.026), women (β= 0.156, 95% CI 0.024-0.288, p = 0.021), and APOE ɛ4 non-carriers (β= 0.140, 95% CI 0.017-0.263, p = 0.026). CONCLUSIONS The association of strictly BG high PVS burden with NfL suggests a role for PVS as markers of neuroaxonal injury, but our results are hypothesis generating and require further replication.

[1]  C. DeCarli,et al.  MRI-Visible Perivascular Spaces and Risk of Incident Dementia , 2022, Neurology.

[2]  A. Charidimou,et al.  Aging, prevalence and risk factors of MRI-visible enlarged perivascular spaces , 2022, Aging.

[3]  A. Charidimou,et al.  Association of Apolipoprotein E ɛ4 Allele with Enlarged Perivascular Spaces , 2022, Annals of neurology.

[4]  L. Kuller,et al.  Association of Serum Neurofilament Light Chain Concentration and MRI Findings in Older Adults , 2021, Neurology.

[5]  Y. Okada,et al.  Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease , 2021, Nature Medicine.

[6]  D. Conen,et al.  Serum neurofilament light in atrial fibrillation: clinical, neuroimaging and cognitive correlates , 2020, Brain communications.

[7]  Andrew D. Johnson,et al.  70-year legacy of the Framingham Heart Study , 2019, Nature Reviews Cardiology.

[8]  P. Calabresi,et al.  Neurofilament light chain as a biomarker in neurological disorders , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[9]  S. Black,et al.  Understanding the role of the perivascular space in cerebral small vessel disease , 2018, Cardiovascular research.

[10]  F. de Leeuw,et al.  Serum Neurofilament Light Chain Levels Are Related to Small Vessel Disease Burden , 2018, Journal of stroke.

[11]  L. Wahlund,et al.  Topography and Determinants of Magnetic Resonance Imaging (MRI)‐Visible Perivascular Spaces in a Large Memory Clinic Cohort , 2017, Journal of the American Heart Association.

[12]  Ludwig Kappos,et al.  Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis , 2017, Annals of neurology.

[13]  Andreas Charidimou,et al.  MRI-visible perivascular spaces in cerebral amyloid angiopathy and hypertensive arteriopathy , 2017, Neurology.

[14]  M. Kloss,et al.  Serum Neurofilament Light Chain Levels Are Associated with Clinical Characteristics and Outcome in Patients with Cervical Artery Dissection , 2015, Cerebrovascular Diseases.

[15]  P. Wolf,et al.  Inflammatory biomarkers, cerebral microbleeds, and small vessel disease , 2015, Neurology.

[16]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[17]  D. Y. Lee,et al.  Lipoprotein Phospholipase A2 and Cerebral Microbleeds in the Framingham Heart Study , 2012, Stroke.

[18]  C. DeCarli,et al.  Multiple Biomarkers and Risk of Clinical and Subclinical Vascular Brain Injury: The Framingham Offspring Study , 2012, Circulation.

[19]  Karen J. Ferguson,et al.  Enlarged Perivascular Spaces on MRI Are a Feature of Cerebral Small Vessel Disease , 2010, Stroke.

[20]  R. Weller,et al.  Microvasculature changes and cerebral amyloid angiopathy in Alzheimer’s disease and their potential impact on therapy , 2009, Acta Neuropathologica.

[21]  Steven Warach,et al.  Cerebral Microbleeds : A Field Guide to their Detection and Interpretation , 2012 .

[22]  F. Paul,et al.  Perivascular spaces--MRI marker of inflammatory activity in the brain? , 2008, Brain : a journal of neurology.

[23]  R. Rouhl,et al.  Virchow-Robin spaces relate to cerebral small vessel disease severity , 2008, Journal of Neurology.

[24]  R. Peters,et al.  Ageing and the brain , 2006, Postgraduate Medical Journal.

[25]  D. Harvey,et al.  Measures of brain morphology and infarction in the framingham heart study: establishing what is normal , 2005, Neurobiology of Aging.